Equity Profile

SUPN

Supernus Pharmaceuticals, Inc.

Health CarePharmaceuticals$2.7B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Supernus Pharmaceuticals, Inc. (SUPN) is a healthcare company focused on developing and commercializing innovative treatments for neurological and psychiatric conditions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and is closely watched by investors.

$0.51

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$205M

Wall Street expectations, options signals, track record, and call prep available with Pro.

SUPN Q2-2026 Earnings Preview

Context

Company Snapshot

Supernus Pharmaceuticals, Inc. (SUPN) is a healthcare company focused on developing and commercializing innovative treatments for neurological and psychiatric conditions. With a market cap of $3 billion, it plays a crucial role in the pharmaceuticals sector, particularly as demand for effective mental health treatments continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-78.10%

Avg Stock Reaction

+1.56%

Last Quarter Recap

In Q1 2026, Supernus reported an EPS of -$0.04, significantly missing the estimate of $0.14. The stock reacted positively, gaining 1.15% the following day despite the disappointing results.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Supernus to report an EPS of $0.51 and revenue of $205 million for Q2 2026. The market is watching closely for any signs of recovery following recent earnings misses.

Bull Case

If Supernus can beat EPS expectations and show strong revenue growth, it may indicate a turnaround in its product performance and investor sentiment could improve significantly.

Bear Case

Conversely, if the company misses on both EPS and revenue, it could raise concerns about its product pipeline and overall financial health, leading to further stock declines.

Key Metrics to Watch

EPS

$0.51

Earnings per share is a key indicator of profitability and is closely watched by investors.

Revenue

$205M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Supernus achieve an EPS of $0.51 or better?

This figure is critical as it will indicate whether the company is on track to recover from previous earnings misses.

What are the revenue figures for Q2 2026?

Revenue performance will provide insights into market demand and the effectiveness of Supernus's product strategies.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for a rebound in Supernus's performance, especially if recent product launches gain traction.

Supporting Evidence

Options are pricing in a 19.16% move, indicating expectations of volatility that may not align with the company's recovery potential.

The stock has historically reacted positively even after earnings misses, suggesting resilience in investor sentiment.

The recent uptick in stock price following earnings misses indicates that investors may be looking for signs of improvement.

Key Risk

If the company reports an EPS of $0.51 or better, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it follows several disappointing earnings reports, and investors are eager for signs of recovery.

Bull Confirmed If

Achieving an EPS of $0.51 or better with revenue exceeding $205 million would confirm a positive outlook.

Bear Confirmed If

An EPS below $0.44 or revenue falling short of $204 million would reinforce negative sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±19.16%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±19.2% while SUPN has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

35.3%

Calls (300)P/C Ratio: 0.67Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Supernus beats expectations, history suggests the stock could rise by about 1.10%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors assess management's commentary.

Miss

A miss could lead to a decline of approximately 1.83%, further emphasizing concerns about the company's financial health.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline developments and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into sales performance of key products.
4Guidance on future earnings expectations and strategic initiatives.
5Responses to analysts' questions regarding previous earnings misses.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Supernus Pharmaceuticals, Inc. (SUPN) is a healthcare company focused on developing and commercializing innovative treatments for neurological and psychiatric conditions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and is closely watched by investors.

$0.51

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$205M

Wall Street expectations, options signals, track record, and call prep available with Pro.

SUPN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-78.10%

Avg Stock Reaction

+1.56%

Last Quarter Recap

In Q1 2026, Supernus reported an EPS of -$0.04, significantly missing the estimate of $0.14. The stock reacted positively, gaining 1.15% the following day despite the disappointing results.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Supernus to report an EPS of $0.51 and revenue of $205 million for Q2 2026. The market is watching closely for any signs of recovery following recent earnings misses.

Bull Case

If Supernus can beat EPS expectations and show strong revenue growth, it may indicate a turnaround in its product performance and investor sentiment could improve significantly.

Bear Case

Conversely, if the company misses on both EPS and revenue, it could raise concerns about its product pipeline and overall financial health, leading to further stock declines.

Key Metrics to Watch

EPS

$0.51

Earnings per share is a key indicator of profitability and is closely watched by investors.

Revenue

$205M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Supernus achieve an EPS of $0.51 or better?

This figure is critical as it will indicate whether the company is on track to recover from previous earnings misses.

What are the revenue figures for Q2 2026?

Revenue performance will provide insights into market demand and the effectiveness of Supernus's product strategies.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for a rebound in Supernus's performance, especially if recent product launches gain traction.

Supporting Evidence

Options are pricing in a 19.16% move, indicating expectations of volatility that may not align with the company's recovery potential.

The stock has historically reacted positively even after earnings misses, suggesting resilience in investor sentiment.

The recent uptick in stock price following earnings misses indicates that investors may be looking for signs of improvement.

Key Risk

If the company reports an EPS of $0.51 or better, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it follows several disappointing earnings reports, and investors are eager for signs of recovery.

Bull Confirmed If

Achieving an EPS of $0.51 or better with revenue exceeding $205 million would confirm a positive outlook.

Bear Confirmed If

An EPS below $0.44 or revenue falling short of $204 million would reinforce negative sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±19.16%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±19.2% while SUPN has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

35.3%

Calls (300)P/C Ratio: 0.67Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Supernus beats expectations, history suggests the stock could rise by about 1.10%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors assess management's commentary.

Miss

A miss could lead to a decline of approximately 1.83%, further emphasizing concerns about the company's financial health.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline developments and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into sales performance of key products.
4Guidance on future earnings expectations and strategic initiatives.
5Responses to analysts' questions regarding previous earnings misses.